Drugs / TIL
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06961786 | Jun 2025 → Nov 2026 expected | metastatic melanoma | TILT Biotherapeutics Ltd. | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIL | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06961786 ↗ |
| Modality | Cell therapy | “Adoptive T cell therapy with TILs” NCT06961786 ↗ |